Takeda announces Andrey Potapov as ICMEA Area Head
Potapov, who was previously assigned as General Manager of Takeda's operations in Russia and Head of the CIS Area, has taken over…
Author
Glenmark launches novel, globally-researched anti-diabetes drug Remogliflozin in India
Remogliflozin is an innovative, patent-protected sodium glucose co-transporter-2 (SGLT2) inhibitor indicated in treatment of…
Cipla receives final approval for generic version of Gilead Sciences’ Letairis
Cipla’s Ambrisentan Tablet, 5 mg and 10 mg, is an AB-rated generic therapeutic equivalent version of Gilead Sciences' Letairis
Decks cleared for expansion of Aurobindo Pharma’s plant in AP
Ministry of Environment, Forests and Climate Change has given clearance to Aurobindo Pharma's drugs and intermediates…
Gilead experimental NASH drug fails another study
California-based Gilead's experimental drug, selonsertib, aimed at treating the fatty liver disease failed to pass yet another…
GSK’s HIV drug wins European panel thumbs-up
The drug company has received approval from the European Medicines Agency (EMA) for its two-drug treatment for HIV infections…
FDA approves expanded label for Regeneron/Sanofi’s cholesterol drug
The FDA’s decision will allow the drug, developed by Regeneron along with Sanofi SA, to be prescribed to reduce the overall risk…
Dr Reddy’s Lab, Cipla arm recall drugs in US market
While Dr Reddy's Laboratories initiated recall after their drugs were found to be exposed to above 50 per cent relative humidity…
Chinese drugs worth over Rs 1.5 Crores seized by CDSCO in Chennai
Over 2300 kg of drugs, manufactured in China and illegally imported by Kawarlal &Co, Madhavaram and Ningbo Hitech Biochemicals…
DuPont chosen to provide probiotics for international pediatric sepsis research
The firm will provide probiotic drugs to the The Hospital for Sick Children (SickKids) for a pediatric sepsis research based in…